Market Overview
The Thailand Peritoneal Dialysis Market is projected to grow from USD 33.58 million in 2023 to approximately USD 57.12 million by 2032, registering a compound annual growth rate (CAGR) of 6.38%.
This market expansion is primarily driven by the increasing prevalence of chronic kidney disease (CKD) and the aging population, both of which are significantly contributing to the rising demand for renal replacement therapies. The shift toward home-based dialysis options is a key trend, as patients seek greater convenience and flexibility in treatment. Growing awareness of the clinical and economic advantages of peritoneal dialysis—such as enhanced quality of life and reduced healthcare expenditure compared to hemodialysis—is further accelerating adoption. Technological advancements, including the development of automated dialysis systems and improved catheter designs, are enhancing both treatment outcomes and patient comfort. Moreover, government initiatives aimed at strengthening healthcare infrastructure and expanding dialysis accessibility are supporting sustained market growth. As the market continues to evolve, factors such as affordability, education, and product innovation will be pivotal to future industry development.
Market Drivers
Government Support and Infrastructure Enhancement
Public sector initiatives and improvements in healthcare infrastructure are critical drivers of Thailand’s peritoneal dialysis market. Government policies, particularly those aimed at expanding dialysis access and financial support, have made treatments more affordable and widely available. A key example is the “PD First” initiative, which prioritizes peritoneal dialysis as a frontline treatment by offering subsidized care and ensuring consistent access to dialysis supplies. These measures are especially impactful in rural regions with limited access to hemodialysis centers. Through targeted healthcare reforms, the Thai government is fostering a more supportive ecosystem for peritoneal dialysis adoption.
Market Challenges Analysis
Patient Awareness and Education Deficiencies
Despite favorable policy and clinical advantages, the peritoneal dialysis market in Thailand faces a major obstacle: limited patient awareness and education. A significant portion of the population—particularly in rural and underserved regions—lacks adequate knowledge about peritoneal dialysis and its potential benefits, leading to a continued preference for hemodialysis. This gap in understanding among both patients and some healthcare providers hinders wider adoption. Addressing this issue will require sustained outreach efforts, educational programs, and advocacy campaigns to promote peritoneal dialysis as a viable, patient-centric treatment option for kidney failure.
Market Segmentation
By Type:
Continuous Ambulatory Peritoneal Dialysis (CAPD)
Automated Peritoneal Dialysis (APD)
By Product:
Peritoneal Dialysis Machines
Peritoneal Dialysis Solutions
Dialysis Catheters
Others
By End-user:
Hospitals
Dialysis Centers
Home Care Settings
By Geography:
Bangkok
Eastern Economic Corridor (EEC)
Chiang Mai
Southern Thailand
Key Player Analysis
Nipro Corporation
Baxter International Inc.
Fresenius Medical Care
Terumo Corporation
Asahi Kasei Medical Co., Ltd.
Huaren Pharmaceutical Co., Ltd.
JMS Co., Ltd.
Kawasumi Laboratories Inc.
Medtronic plc
Pacific Hospital Supply Co., Ltd.
Learn how to effectively navigate the market research process to help guide your organization on the journey to success.
Download eBook